Cannabis Supplements’ Cancer Claims Spark FDA Warnings, Policy Point

The level of agency concern about fraudulent claims made online for the products prompted warning letters from the compliance directors in the drug and food safety centers. FDA is “concerned at the proliferation of therapeutic claims being made about an increasing number” of hemp-based products.